Although there are divergent mechanisms that attenuate inflammation and prevent AOM/DSS-induced carcinogenesis, our data suggested that MA-35 could be an additional option for inhibiting colitis-associated cancer and fibrosis by inhibiting both the TNF-α signaling and TGF-β1 signaling pathways. The gene discussed is TNF; the disease is infectious otitis media.